NCT01397513View on ClinicalTrials.gov

Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

February 28, 2011

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Aspirin

Tablets, 75 or 320mg once daily for 4 weeks. A 4-week wash-out period separated the two treatment periods.

Trial Locations (1)

18288

Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT01397513 - Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes | Biotech Hunter | Biotech Hunter